Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lymphovascular Invasion at the Time of Radical Prostatectomy Adversely Impacts Oncological Outcomes.
Sathianathen NJ, Furrer MA, Mulholland CJ, Katsios A, Soliman C, Lawrentschuk N, Peters JS, Zargar H, Costello AJ, Hovens CM, Bishop C, Rao R, Tong R, Steiner D, Moon D, Thomas BC, Dundee P, Calero JAR, Thalmann GN, Corcoran NM. Sathianathen NJ, et al. Among authors: soliman c. Cancers (Basel). 2023 Dec 26;16(1):123. doi: 10.3390/cancers16010123. Cancers (Basel). 2023. PMID: 38201549 Free PMC article.
Oncological outcomes after attempted nerve-sparing radical prostatectomy (NSRP) in patients with high-risk prostate cancer are comparable to standard non-NSRP: a longitudinal long-term propensity-matched single-centre study.
Furrer MA, Sathianathen N, Gahl B, Corcoran NM, Soliman C, Rodriguez Calero JA, Ineichen GB, Gahl M, Kiss B, Thalmann GN. Furrer MA, et al. Among authors: soliman c. BJU Int. 2024 Jan;133(1):53-62. doi: 10.1111/bju.16126. Epub 2023 Aug 21. BJU Int. 2024. PMID: 37548822
Meticulous initial clinical and pathological staging with standardized long-term follow-up after radical cystectomy is required to validate and improve overall prognostic performance in patients undergoing neoadjuvant chemotherapy for bladder cancer.
Furrer MA, Soliman C, Wuethrich PY. Furrer MA, et al. Among authors: soliman c. Minerva Urol Nephrol. 2024 Feb;76(1):124-126. doi: 10.23736/S2724-6051.23.05563-5. Epub 2024 Jan 9. Minerva Urol Nephrol. 2024. PMID: 38193744 Free article. No abstract available.
Protocol for CAMUS Delphi Study: A Consensus on Comprehensive Reporting and Grading of Complications After Urological Surgery.
Soliman C, Mulholland CJ, Santaguida P, Sathianathen NJ, Lawrentschuk N, Giannarini G, Wuethrich PY, Loeffel LM, Cacciamani GE, Pan HYC, Nair R, Cumberbatch MG, Riedel B, Thomas BC, Kearsley J, Corcoran N, Dundee P, Furrer MA. Soliman C, et al. Eur Urol Focus. 2022 Sep;8(5):1493-1511. doi: 10.1016/j.euf.2022.01.016. Epub 2022 Feb 25. Eur Urol Focus. 2022. PMID: 35221259
42 results